Literature DB >> 24410589

Insights on practice variations in the management of lymphoma and leukemia.

Fausto R Loberiza1, Andrew C Cannon, Anthony J Cannon, Philip J Bierman.   

Abstract

Clinical practice guidelines are systematically developed statements designed to assist practitioners in making decisions about appropriate healthcare for specific clinical circumstances. Their successful implementation should improve quality of care by decreasing inappropriate variation and expediting the application of effective advances to everyday practice. Despite wide promulgation, guidelines have had limited effect on changing physician behaviors. This two-part review article highlights variations in the current recommended management of lymphoma (Part I) and leukemia (Part II), with some focus on targeted therapies. Focus on variations that may be amenable to educational programs designed for physicians were also considered in the review. For the purpose of this report, "variation" is defined as any deviation in the treatment or management of a particular hematologic malignancy where practice guidelines exist. Specific studies that demonstrate factors that may cause variations in clinical outcomes of hematologic malignancies and may contribute to variations in practice are featured.

Entities:  

Keywords:  Leukemia; lymphoma; practice variation

Mesh:

Year:  2014        PMID: 24410589     DOI: 10.3109/10428194.2014.881480

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  4 in total

Review 1.  Persistent Disparities in Adult Hematopoietic Cell Transplantation.

Authors:  David G Crockett; Fausto R Loberiza
Journal:  Curr Hematol Malig Rep       Date:  2015-09       Impact factor: 3.952

2.  Impact of Physicians' Personalities and Behavioral Traits on Treatment-Related Decision-making for Elderly Acute Myeloid Leukemia.

Authors:  Xia Wu; Yi-Nan Jiang; Yue-Lun Zhang; Jia Chen; Yue-Ying Mao; Lu Zhang; Dao-Bin Zhou; Xin-Xin Cao; Jian Li
Journal:  J Gen Intern Med       Date:  2021-01-28       Impact factor: 6.473

Review 3.  Patterns of undertreatment among patients with acute myeloid leukemia (AML): considerations for patients eligible for non-intensive chemotherapy (NIC).

Authors:  Elizabeth Hubscher; Slaven Sikirica; Timothy Bell; Andrew Brown; Verna Welch; Alexander Russell-Smith; Paul D'Amico
Journal:  J Cancer Res Clin Oncol       Date:  2021-08-30       Impact factor: 4.553

4.  Physician uncertainty aversion impacts medical decision making for older patients with acute myeloid leukemia: results of a national survey.

Authors:  Pierre Bories; Sébastien Lamy; Célestine Simand; Sarah Bertoli; Cyrille Delpierre; Sandra Malak; Luc Fornecker; Stéphane Moreau; Christian Récher; Antoine Nebout
Journal:  Haematologica       Date:  2018-07-13       Impact factor: 9.941

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.